Accuracy Coverage Pricing Contact
BB Biotech AG

BB Biotech AG (BION)

BB Biotech AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and autoimmune diseases. The Company’s portfolio comprises between 20 and 35 companies and includes such companies as Celgene, Actelion, Vertex Pharmaceuticals, Gilead, Novo Nordisk, Incyte, Isis Pharmaceuticals, Immunogen, Halozyme Therapeutics, Ariad Pharmaceuticals, Biomarin Pharmaceutical, Alexion Pharmaceuticals, Optimer Pharmaceuticals, Achillion Pharmaceuticals, Swedish Orphan Biovitrum, Dendreon, Bavarian Nordic, Lupin, Glenmark Pharmaceuticals, Strides Arcolab, Endocyte, Probiodrug, and Idenix Pharmaceuticals.

Fundamentals

Optimized Dividends

Annual Dividends

Year Amount Change
2006 0.0c
2007 0.0c 0%
2008 0.0c 0%
2009 0.0c 0%
2010 0.0c 0%
2011 0.0c 0%
2012 0.0c 0%
2013 0.0c 0%
2014 0.0c 0%
2015 225.0c 100%
2016 275.0c 22.2%
2017 330.0c 20.0%
2018 305.0c (7.6%)
2019 Login required
2020 Login required

Dividends

Ex-Div Date Pay Date Year Type Frequency Status Amount
20 Mar 2013 25 Mar 2013 2013 Special Irregularly Paid 450c
21 Mar 2014 26 Mar 2014 2014 Special Irregularly Paid 700c
20 Mar 2015 24 Mar 2015 2015 Special Irregularly Paid 1160c
21 Mar 2016 23 Mar 2016 2015 Final Annually Paid 225c
21 Mar 2016 23 Mar 2016 2016 Special Irregularly Paid 1225c
20 Mar 2017 22 Mar 2017 2016 Final Annually Paid 275c
15 Mar 2018 19 Mar 2018 2017 Final Annually Paid 330c
25 Mar 2019 27 Mar 2019 2018 Final Annually Paid 305c
Login Login 2019 Final Annually Forecast Login
Login Login 2020 Final Annually Forecast Login

BB Biotech AG optimized dividend - 12 month history

Optimized dividend graph demo

BB Biotech AG share price - 12 month history

You're currently viewing outdated and/or artificial data.

Try the real thing now:

Activate Free Trial